ERBB2 and breast cancer: Therefore, this study aimed to systematically analyze the clinical-pathological data of BC patients, exploring the expression of HER-2, its relationship with TILs, and its association with clinical pathological features of BC, to provide new theoretical insights and practical guidance for precision diagnosis and treatment of BC.